Dr. Katie Brenner

Katie co-founded and led Madison-based healthcare startup bluDiagnostics as CEO from 2015 to its acquisition by Amazon in 2020. bluDiagnostics pioneered sensor technology that enabled at-home fertility tests previously confined to clinical settings.

Katie shares Amulet’s vision for a future of healthcare driven by transparency, autonomy, and accessibility. Her technical background—BSEE and MSEE from Stanford University & bioengineering Ph.D. from Caltech—paired with deep expertise developing sensors and product commercialization will be an asset to Amulet’s board.